Method for simultaneously detecting bordetella pertussis and drug-resistant mutation sites thereof and kit
A drug-resistant mutation site and drug-resistant mutation technology, applied in biochemical equipment and methods, microbial determination/inspection, DNA/RNA fragments, etc., to achieve the effects of good specificity, prevention of false positives, and good precision
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Embodiment 1: a preferred embodiment that kit of the present invention forms
[0048] Using the Blast tool to analyze the genome sequence of B. pertussis nucleic acid and drug-resistant mutation sites in Genbank and domestic and foreign literature, select the gene promoter region unique to B. pertussis toxin and the 23S rRNA variable region A2047G of the B. pertussis drug-resistant region. The base mutation site was used as the detection target sequence, and multiple sets of primers and probes were designed and synthesized for the two detection target sequences, and specific primers and probes were designed for the conserved region of the positive quality control product human β-globin gene. The results are shown in Table 1. The primers and probes were synthesized by Sangon Bioengineering (Shanghai) Co., Ltd., including the detection probe of B. pertussis (the 5' end is labeled with FAM fluorescent reporter group, and the 3' end is labeled with BHQ1 fluorescence quenche...
Embodiment 2
[0069] Embodiment 2: the second preferred embodiment that kit of the present invention forms
[0070] On the basis of Example 1, the Bacillus pertussis nucleic acid and drug-resistant mutation site detection kit (Taqman fluorescent probe method) of the present embodiment consists of the following table:
[0071]
[0072] This kit can also be matched with a quantitative standard kit as required.
Embodiment 3
[0073] Embodiment 3: A preferred embodiment of the PCR detection method of B. pertussis nucleic acid and drug-resistant mutation site established by the present invention
[0074] A preferred embodiment of the Bacillus pertussis nucleic acid and drug-resistant mutation site PCR detection method established by the present invention is as follows:
[0075] 1. Genomic DNA extraction from samples to be tested
[0076] Take 50 μL of the oropharyngeal swab sample to be tested and the negative control (Hep-2), centrifuge briefly and take the supernatant, and use the nucleic acid extraction or purification reagent produced by Guangdong Hexin Health Technology Co., Ltd. , operate in strict accordance with the instructions.
[0077] 2. Preparation of 20 μL of B. pertussis and drug resistance detection amplification reaction solution
[0078] Prepare 20 μL of amplification reaction solution for B. pertussis and drug resistance detection according to the following composition:
[0079]...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


